Benzinga | May 17, 2021 10:13AM EDT

Canaccord Genuity Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $193

Canaccord Genuity maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $179 to $193.